Insights

Market Position Early-stage biotechnology focused in Madrid with a small team suggests a target for strategic partnerships and contract research collaborations to accelerate R&D milestones and access regional funding opportunities.

Revenue Opportunity Current revenue under one million and a lean headcount indicate a potential for contract services, co-development deals, or sponsored research arrangements with mid-sized biotechs seeking nimble partners.

Competitive Niche Similar company benchmarks show competition from both small biotech players and larger biotechs; identify unique value propositions such as specialized platforms or assays to differentiate offerings.

Geographic Focus Based in Madrid with European market exposure; target EU-based pharma and biotech buyers looking for nearshore collaborations and regulatory-friendly partners to shorten development timelines.

Growth Triggers Lack of disclosed funding details suggests appetite for grant support, strategic investors, or milestone-driven funding; tailor outreach around funding readiness, pilot programs, and risk-sharing mechanisms.

Similar companies to Onkaido Therapeutics

Onkaido Therapeutics's Email Address Formats

Onkaido Therapeutics uses at least 0 email formats:
Onkaido Therapeutics Email FormatsExamplePercentage

Frequently Asked Questions

What is Onkaido Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Onkaido Therapeutics's official website is onkaido.com and has social profiles on LinkedIn.

How much revenue does Onkaido Therapeutics generate?

Minus sign iconPlus sign icon
As of August 2026, Onkaido Therapeutics's annual revenue is estimated to be <$1M.

What is Onkaido Therapeutics's SIC code and NAICS code?

Minus sign iconPlus sign icon
Onkaido Therapeutics's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Onkaido Therapeutics have currently?

Minus sign iconPlus sign icon
As of August 2026, Onkaido Therapeutics has approximately 11 employees across . Explore Onkaido Therapeutics's employee directory with LeadIQ.

What industry does Onkaido Therapeutics belong to?

Minus sign iconPlus sign icon
Onkaido Therapeutics operates in the Biotechnology Research industry.
Onkaido Therapeutics logo

Onkaido Therapeutics

Biotechnology ResearchCommunity of Madrid, Spain11-50 Employees

Onkaido Therapeutics is a biotechnology research company headquartered in Madrid, Spain, operating within the biotechnology sector. The organization lists an employee count in the range of 11 to 50 personnel. Its stated address places the headquarters at 16 Edificio Adriana Calle Laguna Del Marquesado nª 19 Nave 1ª Planta in the Community of Madrid. The company maintains a website at https://onkaido.com. Reported annual revenue is in the range of $0 to $1 million, indicating a startup-to-early-stage scale within the biotechnology landscape.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • <$1M

    Onkaido Therapeutics's revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.